Search Within

Anthony R Mato

Refine Results
Formats
  1. Meeting Abstract (17)
  2. Journal Article (11)
Groups
  1. Adult Leukemia (28)
  2. Center for Hematologic Malignancies (28)
  3. Hematologic Oncology, Division of (1)
  4. Lymphoma (1)
  5. Lymphoma Service (1)
People
  1. Lindsey Roeker (6)
  2. Andrew Zelenetz (1)
  3. Charlene Kabel (1)
  4. Colleen Dorsey (1)
Years
  1. 2019 (2)
  2. 2018 (26)
Publications
  1. Blood (13)
  2. Journal of Clinical Oncology (5)
  3. Clinical Lymphoma, Myeloma and Leukemia (2)
  4. Haematologica (2)
  5. American Journal of Hematology (1)
  6. American Society of Clinical Oncology Educational Book (1)

More Publications

Publishers
  1. American Society of Hematology (13)
  2. American Society of Clinical Oncology (6)
  3. Elsevier Inc. (2)
  4. Ferrata Storti Foundation (2)
  5. Elsevier Science Ltd. (1)
  6. Harborside Press (1)

More Publishers

Results (28)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, version 2.2019: Featured updates to the NCCN Guidelines
    Journal Article

    Wierda, W. G.; Byrd, J. C.; Abramson, J. S.; Bilgrami, S. F.; Bociek, G.; Brander, D.; Brown, J.; Chanan-Khan, A. A.; Chavez, J. C.; Coutre, S. E.; more...
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save
  • Combinations or sequences of targeted agents in CLL: Is the whole greater than the sum of its parts (Aristotle, 360 BC)?
    Journal Article

    Yazdy, M. S.; Mato, A. R.; Cheson, B. D.
    Blood (2019)

    Fulltext@MSK | Save
  • Real-world treatment patterns among a contemporary cohort of commercially insured mantle cell lymphoma patients in the United States
    Meeting Abstract

    Roeker, L. E.; Kabadi, S.; Burudpakdee, C.; Near, A.; Wada, K.; Mato, A. R.
    Blood (2018)

    Fulltext@MSK | Save
  • Characteristics and outcomes of ibrutinib-associated musculoskeletal toxities in CLL patients
    Meeting Abstract

    Rhodes, J.; Mato, A. R.; Winchell, N.; Kennard, K.; Gerson, J. N.; Landsburg, D. J.; Nasta, S. D.; Svoboda, J.; Schuster, S. J.
    Blood (2018)

    Fulltext@MSK | Save
  • Comparison of costs and health care resource utilization (HRU) in chronic lymphocytic leukemia (CLL) patients treated with venetoclax (VEN) or chemotherapy (CT)/chemoimmunotherapy (CIT)
    Meeting Abstract

    Nabhan, C.; Mato, A. R.; Kish, J. K.; Nero, D.
    Blood (2018)

    Fulltext@MSK | Save
  • Cost-effectiveness comparison between ibrutinib, chemotherapy, and chemoimmunotherapy in front-line treatment of chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Nabhan, C.; Nero, D.; Lee, C. H.; Kish, J. K.; Mato, A. R.
    Blood (2018)

    Fulltext@MSK | Save
  • Venetoclax as monotherapy or in combination: Patterns of use and predictors of outcomes in an international multicenter study of CLL patients
    Meeting Abstract

    Mato, A. R.; Roeker, L. E.; Eyre, T. A.; Nabhan, C.; Lamanna, N.; Hill, B. T.; Brander, D. M.; Barr, P.; Lansigan, F.; Cheson, B.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Prognostic testing and treatment approaches in patients with chronic lymphocytic leukemia: Clinical experience from an interim analysis of the informCLL (TM) real-world registry
    Meeting Abstract

    Mato, A. R.; Barrientos, J. C.; Brander, D. M.; Pagel, J. M.; Gutierrez, M.; Kadish, K.; Tomlinson, B.; Ghosh, N.; Giafis, N.; Ipe, D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes of patients with CLL treated with chemoimmuno- and novel agent-based therapy: A multicenter study
    Meeting Abstract

    Mato, A. R.; Yazdy, M. S.; Hill, B. T.; Shadman, M.; Tuncer, H.; Winter, A. M.; Kennard, K.; Allan, J. N.; Ujjani, C. S.; Brander, D. M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Phase I study of first-in-class oral triplet therapy DTRM-555 in relapsed/refractory lymphoma patients through fixed-dose combination and synthetic lethality
    Meeting Abstract

    Huntington, S. F.; Schuster, S. J.; He, W.; Shen, T.; Walker, H.; Leary, L.; Boyhen, K.; Gill, J.; Chatburn, E. T.; Kennard, K.; more...
    Blood (2018)

    Fulltext@MSK | Save